https://pmc.ncbi.nlm.nih.gov/articles/PMC12082521/
FOLFOX-HAIC combined with PD-1 inhibitor immunotherapy significantly improves survival in patients...
Objective: To evaluate the effect of FOLFOX-HAIC combined with PD-1 inhibitor immunotherapy on the survival of patients with advanced hepatocellular carcinoma...
pd 1 inhibitor
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1533467/full
Frontiers | Updates from a single-center phase 2 study of PD-1 inhibitor combined with...
IntroductionAnti-PD-1 monotherapy has shown limited clinical efficacy in patients with relapsed/refractory acute myeloid leukemia (r/r AML). Our study aimed ...